Coping with the financiers: attracting venture capital investors and end-users in the biomaterials industry

Technology Analysis and Strategic Management

Volumn 26, Issue 7, 2014, Pages 797-809

  Styhre, Alexander ^a  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

Author keywords

biomaterials; health care innovations; medical devices; university spin outs; venture capital

Indexed keywords

CAPITAL FLOW; COMMERCIALIZATION; HEALTH CARE; HEALTH SERVICES; INNOVATION; MEDICINE; REGULATORY FRAMEWORK; TECHNOLOGICAL DEVELOPMENT;

SWEDEN; UNITED STATES;

EID: 84904036027     PISSN: 09537325     EISSN: 14653990     Source Type: Journal    
DOI: 10.1080/09537325.2014.900170     Document Type: Article

References (34)

1. Andrews, L., and D. Nelkin. 2001. Human bazaar: The market for human tissue in the biotechnology age. New York: Crown.
2. Berman, E.P. 2008. Why did universities start patenting? Institution-building and the road to the Bayh-Dole Act. Social Studies of Science 38: 835-71. doi: 10.1177/0306312708098605
3. Berman, E.P. 2012. Creating the market university: How academic science became an economic engine. Princeton, NJ: Princeton University Press.
4. Boardman, P.C., and E.A. Corley. 2008. University research centers and the composition of research collaborations. Research Policy 37: 900-13. doi: 10.1016/j.respol.2008.01.012
5. Carolan, M.S. 2010. The mutability of biotechnology patents: From unwieldly products of nature to independent 'objects/s'. Theory, Culture & Society 27, no. 1: 110-29. doi: 10.1177/0263276409350360
6. Cherry, M.J. 2005. Kidney for sale by owner: Transplantation and the market. Washington, DC: Georgetown University Press.
7. Davey, S.M., M. Brennan, B.J. Meenan, and R. McAdam. 2011. Innovation in the medical device sector: An open business model approach for high-tech small firms. Technology Analysis & Strategic Management 23: 807-24. doi: 10.1080/09537325.2011.604152
8. Dickenson, D. 2008. Body shopping: The economy fuelled by flesh and blood. Oxford: Oneworld.
9. Etzkowitz, H. 2003. Research groups as 'quasi-firms': The invention of the entrepreneurial university. Research Policy 32: 109-21. doi: 10.1016/S0048-7333(02)00009-4
10. Faulkner, A. 2009. Regulatory policy as innovation: Constructing rules of engagement for a technological zone of tissue engineering in the European Union. Research Policy 38: 637-46. doi: 10.1016/j.respol.2009.01.017
11. Friedlander, R., and R.R. Alford. 1991. Bringing society back in: Symbols, practices and institutional contradictions, in The New Institutionalism in Organizational Analysis, ed. P.J. DiMaggio and W.W. Powell, 232-63. Chicago, IL: University of Chicago Press.
12. Grimaldi, R., M. Kenney, D.S. Siegel, and M. Wright. 2011. 30 years after Bayh-Dole: Reassessing academic entrepreneurship. Research Policy 40: 1045-57. doi: 10.1016/j.respol.2011.04.005
13. Hopkins, M.M., P.A. Martin, P. Nightingale, A. Kraft, and S. Mahdi. 2007. The myth of a biotech revolution: An assessment of technological, clinical and organizational change, Research Policy 36: 566-89. doi: 10.1016/j.respol.2007.02.013
14. Knockaert, M., M. Wright, B. Clarysse, and A. Lockett. 2010. Agency and similarity effects and the VC's attitude towards academic spin-out investing. Journal of Technology Transfer 35: 567-84. doi: 10.1007/s10961-009-9138-y
15. Lam, A. 2007. Knowledge networks and careers. Academic scientists in industry-university links. Journal of Management Studies 44: 993-1016. doi: 10.1111/j.1467-6486.2007.00696.x
16. Lazonick, W., and Ö. Tulum. 2011. US biopharmaceutical finance and the sustainability of the biotech business model. Research Policy 40: 1170-87. doi: 10.1016/j.respol.2011.05.021
17. Mazzoleni, R. 2011. Before Bayh-Dole: Public research funding, patents, and pharmaceutical innovation (1945-1965). Industrial and Corporate Change 20: 721-49. doi: 10.1093/icc/dtr017
18. Mirowski, P. 2011. Science-mart: Privatizing American science. Cambridge, MA: Harvard University Press.
19. Niosi, J. 2011. Complexity and path dependence in biotechnology innovation systems. Industrial and Corporate Change 20: 1795-826. doi: 10.1093/icc/dtr065
20. Phillips, W., T. Johnsen, N. Caldwell, and J.B. Chaudhuri. 2011. The difficulties of supplying new technologies into highly regulated markets: the case of tissue engineering. Technology Analysis & Strategic Management 23: 213-26. doi: 10.1080/09537325.2011.550391
21. Pisano, G.O. 2006. Science business: The promise, the reality and the future of biotech. Boston, MA: Harvard Business School Press.
22. Powell, W.W., and K. Snellman. 2004. The knowledge economy. Annual Review of Sociology 30: 199-220. doi: 10.1146/annurev.soc.29.010202.100037
23. Rasmussen, E., and R. Sørheim. 2012. How governments seek to bridge the financing gap for university spin-offs: Proof-of-concept, pre-seed, and seed funding. Technology Analysis & Strategic Management 24: 663-78. doi: 10.1080/09537325.2012.705119
24. Rasmussen, E., S. Mosey, and M. Wright. 2011. The evolution of entrepreneurial competencies: A longitudinal study of university spin-off venture emergence. Journal of Management Studies 48: 1314-24. doi: 10.1111/j.1467-6486.2010.00995.x
25. Rose, N.S. 2007. The politics of life itself: Biomedicine, power and subjectivity in the twenty-first century. Princeton, NJ: Princeton University Press.
26. Spar, D. 2006. The baby business: How money, science, and politics drive the commerce of conception. Boston, MA: Harvard Business School Press.
27. Sternitzke, C. 2010. Knowledge sources, patent protection, and commercialization of pharmaceutical innovation. Research Policy 39: 810-21. doi: 10.1016/j.respol.2010.03.001
28. Styhre, A., and F. Lind. 2010. Balancing centripetal and centrifugal forces in the entrepreneurial university: A study of ten research centres in a technical university. Technology Analysis & Strategic Management 22: 909-24. doi: 10.1080/09537325.2010.520471
29. Thirumalai, S., and K.K. Sinha. 2011. Product recalls in the medical device industry: An empirical exploration of the sources and financial consequences. Management Science 57: 376-392. doi: 10.1287/mnsc.1100.1267
30. Thornton, P.H., and W. Ocasio. 2008. Institutional logics, in The Sage handbook of organizational institutionalism, ed. Greenwood, R. Oliver C., K. Sahlin and R. Suddaby, 99-129. Thousand Oaks, CA: Sage.
31. Toker, U., and D.O. Gray. 2008. Innovation spaces. Workspace planning and innovation in U.S. university research centers. Research Policy 37: 309-29. doi: 10.1016/j.respol.2007.09.006
32. Toole, A.A. 2012. The impact of public basic research on industrial innovation: Evidence from the pharmaceutical industry. Research Policy 41: 1-12. doi: 10.1016/j.respol.2011.06.004
33. Waldby, C., and R. Mitchell. 2006. Tissue economies: Blood, organs, and cell lines in late capitalism. Durham, NC: Duke University Press.
34. Wright, M., A. Lockett, B. Clarysse, and M. Binks. 2006. University spin-out companies and venture capital. Research Policy 35: 481-501. doi: 10.1016/j.respol.2006.01.005